SUBSCRIBE
SUBSCRIBE
News   Policy

Veridex, LLC Cancer Test Lacks Long Term Data Say US FDA Staff

November 16, 2006 | 
1 min read
WASHINGTON, Nov 15 (Reuters) - Data on Veridex LLC's lab test to quickly detect breast cancer that has spread to lymph nodes lacks long-term information on survival, U.S. regulatory staff said in documents released on Wednesday.

>>> Discuss This Story

Regulatory
MORE ON THIS TOPIC
Chess made from China and EU, USA flags. Europe Union, USA and China relations
China
Summit, Merck must navigate new regulatory terrain in China-first cancer landscape
July 27, 2026
 · 
10 min read
 · 
Heather McKenzie
A crowd of abstract multicolored silhouettes of people and conversational bubbles above them, made in the style of a collage. A metaphor for society and cooperation.
Regulatory
Amgen deploys patients to defend troubled Tavneos in FDA hearing request
July 24, 2026
 · 
4 min read
 · 
Annalee Armstrong
Winter season driving tips and traffic regulation rules. Heavy snow covered "snow and ice" road sign. Close-up view. Flat vector illustration template.
Complete response letters
Update: FDA does not freeze CRL trove as ‘radical transparency’ push hits speedbump
July 23, 2026
 · 
3 min read
 · 
Tristan Manalac
A boxing match between the USA and China
China
US ‘eroding’ lead in rare diseases a matter of national security: Report
July 22, 2026
 · 
4 min read
 · 
Tristan Manalac